Simplinext Overview

  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Debt
  • Investors
  • 1

Simplinext General Information

Description

Developer of in-vitro toxicology testing technology. The company markets the next generation of consumable labware for the design of early stage toxicity testing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Rue Fritz-Oppliger 18
  • 2504 Biel
  • Switzerland
+41 078 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Simplinext Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - General 000.00 Completed Startup
1. Accelerator/Incubator 01-Jan-2015 000.00 000.00 Completed Startup
To view Simplinext’s complete valuation and funding history, request access »

Simplinext Executive Team (1)

Name Title Board Seat Contact Info
Silvia Angeloni Business Development Manager
To view Simplinext’s complete executive team members history, request access »

Simplinext Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Simplinext Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Venture Kick Accelerator/Incubator Minority 000 0000 000000 0
To view Simplinext’s complete investors history, request access »